PDLI Stock-Based Compensation
Pdl Biopharma Inc · Stock-Based Compensation

PDLI Stock-Based Compensation
Latest reported$20.52Mperiod ending
PDLI Stock-Based Comp ($0.00 → $20.52M)
Annual stock-based compensation
High-resolution chart · PNG
PDLI stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 7,119,000 | |
| 4,758,000 | |
| 3,138,000 | |
| 3,742,000 | |
| 2,045,000 | |
| 1,501,000 | |
| 872,000 | |
| 937,000 | |
| 387,000 | |
| 662,000 | |
| 821,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |